Reversible tetraplegia after percutaneous nephrostolithotomy and septic shock: a case of critical illness polyneuropathy and myopathy with acute onset and complete recovery

BMC Nephrology

Hong-Liang Zhang¹  Hong-Yan Li²  Rui Zhao²  Yi Hou²  Xiang-Bo Kong²  Li-Min Wu¹  Hai Li¹ 

[1] Department of Neurology, The First Bethune Hospital of Jilin University, Jilin University, Xinmin Street 71#, 130021, Changchun, China;Department of Urology, The China-Japan Union Hospital of Jilin University, Changchun, China

关键词: Guillain-Barré syndrome;    Sepsis;    Percutaneous nephrostolithotomy;    Critical illness myopathy;    Critical illness polyneuropathy;   

Others  :  1083002
DOI  :  10.1186/1471-2369-14-36

 received in 2012-03-04, accepted in 2013-02-06,  发布年份 2013

【 摘 要 】

Background

Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are complications causing weakness of respiratory and limb muscles in critically ill patients. As an important differential diagnosis of Guillain-Barré syndrome (GBS), CIP and CIM should be diagnosed with caution, after a complete clinical and laboratory examination. Although not uncommon in ICU, CIP and CIM as severe complications of percutaneous nephrostolithotomy (PNL) have not been documented in literature.

Case presentation

A 48-year-old Chinese woman was referred to our hospital, complaining of occasional pain in the right lower back for one month. Lithiasis was diagnosed by ultrasonographical and radiological examinations on the urinary system. PNL was indicated and performed. The patient developed CIP and CIM on the fourth day after PNL. Early recognition and treatment of the severe complications contributed to a satisfactory recovery of the patient.

Conclusion

This case expands our understanding of the complications of PNL and underscores the importance of differentiating CIP/CIM from GBS in case of such patients developing weakness after the treatment. Clinical characteristics and examination results should be carefully evaluated to make the diagnosis of CIP or CIM. Both anti-septic prophylaxis and control of hyperglycemia might be effective for the prevention of CIP or CIM; aggressive treatment on sepsis and multiple organ failure is considered to be the most effective measure to reduce the incidence of CIP/CIM.

【 授权许可】

   
2013 Li et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Lacomis D, Zochodne DW, Bird SJ: Critical illness myopathy. Muscle Nerve 2000, 23:1785-1788.
• [2]Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA: Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987, 110:819-841.
• [3]Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G: Clinical review: critical illness polyneuropathy and myopathy. Crit Care 2008, 12:238. BioMed Central Full Text
• [4]Witt NJ, Zochodne DW, Bolton CF, Grand’Maison F, Wells G, Young GB, Sibbald WJ: Peripheral nerve function in sepsis and multiple organ failure. Chest 1991, 99:176-184.
• [5]Bercker S, Weber-Carstens S, Deja M, Grimm C, Wolf S, Behse F, Busch T, Falke KJ, Kaisers U: Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005, 33:711-715.
• [6]Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, De Maria G, Antonini L, Rizzuto N, Candiani A: Critical illness myopathy and neuropathy. Lancet 1996, 347:1579-1582.
• [7]Skolarikos A, Alivizatos G, de la Rosette JJ: Percutaneous nephrolithotomy and its legacy. Eur Urol 2005, 47:22-28.
• [8]Skolarikos A, de la Rosette J: Prevention and treatment of complications following percutaneous nephrolithotomy. Curr Opin Urol 2008, 18:229-234.
• [9]Yamaguchi A, Skolarikos A, Buchholz NP, Chomón GB, Grasso M, Saba P, Nakada S, de la Rosette J, Clinical Research Office Of The Endourological Society Percutaneous Nephrolithotomy Study Group: Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the clinical research office of the endourological society percutaneous nephrolithotomy global study. J Endourol 2011, 25:933-939.
• [10]McAleer IM, Kaplan GW, Bradley JS, Carroll SF, Griffith DP: Endotoxin content in renal calculi. J Urol 2003, 169:1813-1814.
• [11]Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J: Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 1991, 146:955-960.
• [12]Latronico N, Guarneri B: Critical illness myopathy and neuropathy. Minerva Anestesiol 2008, 74:319-323.
• [13]Koch S, Spuler S, Deja M, Bierbrauer J, Dimroth A, Behse F, Spies CD, Wernecke KD, Weber-Carstens S: Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry 2011, 82:287-293.
• [14]Hund E: Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 2001, 248:929-934.
• [15]de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meché FG: Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001, 29:2281-2286.
• [16]Nanas S, Kritikos K, Angelopoulos E, Siafaka A, Tsikriki S, Poriazi M, Kanaloupiti D, Kontogeorgi M, Pratikaki M, Zervakis D, Routsi C, Roussos C: Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand 2008, 118:175-181.
• [17]Zink W, Kollmar R, Schwab S: Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol 2009, 5:372-379.
• [18]Hermans G, Schrooten M, Van Damme P, Berends N, Bouckaert B, De Vooght W, Robberecht W, Van den Berghe G: Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care 2009, 13:R5. BioMed Central Full Text
• [19]Friedrich O: Critical illness myopathy: sepsis-mediated failure of the peripheral nervous system. Eur J Anaesthesiol Suppl 2008, 42:73-82.
• [20]Latronico N, Bolton CF: Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011, 10:931-941.
• [21]Tzanis G, Vasileiadis I, Zervakis D, Karatzanos E, Dimopoulos S, Pitsolis T, Tripodaki E, Gerovasili V, Routsi C, Nanas S: Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness. BMC Anesthesiol 2011, 11:14. BioMed Central Full Text
• [22]Rooney KA, Thomas NJ: Severe pulmonary hypertension associated with the acute motor sensory axonal neuropathy subtype of Guillain-Barré syndrome. Pediatr Crit Care Med 2010, 11:e16-e19.
• [23]Hughes RA, Cornblath DR: Guillain-Barré syndrome. Lancet 2005, 366:1653-1666.
• [24]Algahtani H, Moulin DE, Bolton CF, Abulaban AA: Guillain-Barre syndrome following cardiac surgery. Difficult diagnosis in the intensive care unit. Neurosciences (Riyadh) 2009, 14:374-378.
• [25]Green DM: Weakness in the ICU: Guillain-Barré syndrome, myasthenia gravis, and critical illness polyneuropathy/myopathy. Neurologist 2005, 11:338-347.
• [26]van der Meché FG, van Doorn PA: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol 1995, 37:S14-S31.
• [27]Latronico N, Rasulo FA, Recupero D, Beindorf A, Liberini P, Stefini R, Candiani A: Acute quadriplegia with delayed onset and rapid recovery. Case report. J Neurosurg 1998, 88:769-772.
• [28]Tennilä A, Salmi T, Pettilä V, Roine RO, Varpula T, Takkunen O: Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000, 26:1360-1363.
• [29]Khan J, Harrison TB, Rich MM, Moss M: Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006, 67:1421-1425.
• [30]Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar A, Garnacho-Montero MC, Moyano-Del-Estad MR: Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001, 27:1288-1296.
• [31]Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G: Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2009, (1):CD006832.
• [32]Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ, NICE-SUGAR Study Investigators: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
• [33]Karatzanos E, Gerovasili V, Zervakis D, Tripodaki ES, Apostolou K, Vasileiadis I, Papadopoulos E, Mitsiou G, Tsimpouki D, Routsi C, Nanas S: Electrical muscle stimulation: an effective form of exercise and early mobilization to preserve muscle strength in critically ill patients. Crit Care Res Pract 2012, 2012:432752.
• [34]Needham DM: Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA 2008, 300:1685-1690.
• [35]Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP: Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373:1874-1882.
• [36]Novak P, Vidmar G, Kuret Z, Bizovičar N: Rehabilitation of critical illness polyneuropathy and myopathy patients: an observational study. Int J Rehabil Res 2011, 34:336-342.